502 results on '"Lee, Randall J."'
Search Results
2. Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study
3. Local decorin delivery via hyaluronic acid microrods improves cardiac performance, ventricular remodeling after myocardial infarction
4. Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction
5. Acute alcohol exposure and electrocardiographic changes: Finding from the HOLIDAY trial
6. A Randomized Trial of High vs Standard Power Radiofrequency Ablation for Pulmonary Vein Isolation: SHORT-AF
7. The Strengths and Weaknesses of Left Atrial Appendage Ligation or Exclusion (LARIAT, AtriaClip, Surgical Suture)
8. Randomized Comparison of a Radiofrequency Wire Versus a Radiofrequency Needle System for Transseptal Puncture
9. Hybrid epicardial and endocardial sinus node–sparing ablation therapy for inappropriate sinus tachycardia: Rationale and design of the multicenter HEAL-IST IDE trial
10. The Value of Programmed Ventricular Extrastimuli From the Right Ventricular Basal Septum During Supraventricular Tachycardia
11. Engineering stem cell therapeutics for cardiac repair
12. The Strengths and Weaknesses of Left Atrial Appendage Ligation or Exclusion (LARIAT, AtriaClip, Surgical Suture)
13. A Feasibility Study of [18F]F-AraG Positron Emission Tomography (PET) for Cardiac Imaging–Myocardial Viability in Ischemia–Reperfusion Injury Model.
14. Premature Atrial Contraction Location and Atrial Fibrillation Inducibility
15. Percutaneous epicardial approach for LAA ligation
16. Abstract 9803: Randomized Comparison of a Radiofrequency Wire versus a Radiofrequency Needle System for Transseptal Puncture
17. A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Alcohol to Assess Changes in Atrial Electrophysiology
18. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results
19. Anatomic Considerations for Epicardial and Endocardial Left Atrial Appendage Closure
20. An overview of current and emerging devices for percutaneous left atrial appendage closure
21. Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial.
22. Hybrid Endo-Epicardial Therapies for Advanced Atrial Fibrillation.
23. Injectable hyaluronic acid based microrods provide local micromechanical and biochemical cues to attenuate cardiac fibrosis after myocardial infarction
24. Use of Programmed Ventricular Extrastimulus During Supraventricular Tachycardia to Differentiate Atrioventricular Nodal Re-Entrant Tachycardia From Atrioventricular Re-Entrant Tachycardia
25. Photoplethysmography based atrial fibrillation detection: a review
26. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke
27. Comparison of Gene-Transfer Efficiency in Human Embryonic Stem Cells
28. Abstract 12935: Predictors of Long-term Success After Catheter Ablation of Premature Ventricular Complexes
29. Postoperative Coagulation Changes in Patients after Epicardial Left Atrial Appendage Occlusion Varies Based on the Left Atrial Appendage Size.
30. Left atrial appendage ligation with the next generation LARIAT+ suture delivery device: Early clinical experience
31. Left Atrial Appendage Ligation in Nonvalvular Atrial Fibrillation Patients at High Risk for Embolic Events With Ineligibility for Oral Anticoagulation: Initial Report of Clinical Outcomes
32. The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results
33. Discrete microstructural cues for the attenuation of fibrosis following myocardial infarction
34. The Role of the Left Atrial Appendage in Stroke and Arrhythmia Provocation
35. The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model
36. Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction
37. Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart
38. Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation: Initial Clinical Experience
39. MP-470554-001 THE VALUE OF FUNCTIONAL FACSICULAR BLOCK IN PATIENTS WITH ATRIOVENTRICULAR REENTRANT TACHYCARDIA
40. Alcohol and Vagal Tone as Triggers for Paroxysmal Atrial Fibrillation
41. SIMULTANEOUS EPICARDIAL AND ENDOCARDIAL MAPPING OF POSTERIOR LEFT ATRIUM DURING SINUS RHYTHM AND ATRIAL FIBRILLATION IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
42. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
43. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure
44. Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT
45. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design
46. Reversible High-Grade Atrioventricular Block Associated With Cocaine Use
47. Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression
48. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat
49. Intracardiac and extracardiac markers of inflammation during atrial fibrillation
50. Differences in accessory pathway location by sex and race
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.